Is JCRRF or ORCC a better dividend investment in 2026?

JCRRF currently yields 3.22% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: ORCC offers higher current income.

What is the dividend yield difference between JCRRF and ORCC?

JCRRF has a forward dividend yield of 3.22% ($0.13/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 6.57 percentage points.

Home › Compare › JCRRF vs ORCC

JCRRF vs ORCC: Dividend Comparison 2026

JCRRF yields 3.22% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 JCRRF wins by $590.30M in total portfolio value

INVESTMENT

TIME HORIZON10 years

JCRRF

● Live price

3.22%

Share price

$4.17

Annual div

$0.13

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$590.33M

Annual income

$557,098,169.44

Full JCRRF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — JCRRF vs ORCC

📍 JCRRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	JCRRF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, JCRRF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

JCRRF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JCRRF

Annual income on $10K today (after 15% tax)

$273.77/yr

After 10yr DRIP, annual income (after tax)

$473,533,444.02/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, JCRRF beats the other by $473,533,443.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JCRRF + ORCC for your $10,000?

JCRRF: 50%ORCC: 50%

100% ORCC50/50100% JCRRF

Portfolio after 10yr

$295.17M

Annual income

$278,549,085.24/yr

Blended yield

94.37%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

JCRRF

No analyst data

Altman Z

1.4

Piotroski

4/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JCRRF buys

ORCC buys

No recent congressional trades found for JCRRF or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricJCRRFORCC

Forward yield	3.22%	9.79% ✓
Annual dividend / share	$0.13	$1.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	-50%
Portfolio after 10y	$590.33M ✓	$21.4K
Annual income after 10y	$557,098,169.44 ✓	$1.04
Total dividends collected	$587.89M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: JCRRF vs ORCC ($10,000, DRIP)

Year	JCRRF Portfolio	JCRRF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$11,344	$644.17	$11,190	$489.61	+$154.00 → JCRRF
2	$13,504	$1,365.91	$12,229	$256.01	+$1.3K → JCRRF
3	$17,489	$3,039.22	$13,216	$130.74	+$4.3K → JCRRF
4	$26,070	$7,356.96	$14,207	$66.02	+$11.9K → JCRRF
5	$48,393	$20,498.67	$15,234	$33.17	+$33.2K → JCRRF
6	$122,906	$71,124.57	$16,317	$16.62	+$106.6K → JCRRF
7	$469,147	$337,637.75	$17,468	$8.32	+$451.7K → JCRRF
8	$2,910,974	$2,408,986.96	$18,695	$4.16	+$2.89M → JCRRF
9	$31,053,709	$27,938,966.99	$20,006	$2.08	+$31.03M → JCRRF
10	$590,325,638	$557,098,169.44	$21,407	$1.04	+$590.30M → JCRRF

JCRRF vs ORCC: Complete Analysis 2026

JCRRF — Stock

JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.

Full JCRRF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this JCRRF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JCRRF vs SCHD JCRRF vs JEPI JCRRF vs O JCRRF vs KO JCRRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.